RA
THRN

Royce & Associates’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Royce & Associates’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-189,755
Closed -$892K – 960
2023
Q2 		$892K Buy
189,755
+55,455
+41% +$255K 0.01% 769
2023
Q1 		$620K Buy
+134,300
New +$591K 0.01% 825

Other funds holding THRN

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royce & Associates's THRN Position: Q3 2023 in Review

Royce & Associates sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q3 2023, closing a stake of 189,755 shares — an estimated $892K sold.

Royce & Associates first reported a position in THRN in Q1 2023 and held it in 2 quarters. The position peaked at $892K in Q2 2023. 59 funds tracked by Wall St. Rank hold THRN as of Q3 2023.

  • Royce & Associates reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Royce & Associates sold 189,755 Thorne Healthtech, Inc. Common Stock shares in Q3 2023, an estimated $892K.
  • Royce & Associates first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Royce & Associates's Thorne Healthtech, Inc. Common Stock position peaked at $892K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q3 2023.

Based on Royce & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.